PhenomeX is a Digital Cell Biology company focused on enabling and accelerating the development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for single cells in parallel and can also deliver the live biology customers desire in the form of the cells. Co.'s platform captures and interprets the qualitative language of biology and translates it into single-cell specific digital information, referred to as Digital Cell Biology. Co. is focused on the markets of antibody therapeutics, cell therapy and synthetic biology with its platform.